Alphabeta and gammadelta T cell subsets in chronic renal failure in children on dialysis treatment

Pediatr Int. 2002 Feb;44(1):32-6. doi: 10.1046/j.1442-200x.2002.01501.x.

Abstract

Background: Impaired immunity, particularly cell-mediated, is one of the features of chronic renal failure. This also concerns impaired T cell dependent responsiveness.

Methods: The expression of T cell surface antigens (CD3, CD25, TCRalphabeta, TCRgammadelta) was evaluated on peripheral blood (PB) mononuclear cells using two-color flow cytometry in 10 children on continuous ambulatory peritoneal dialysis (CAPD) and in 13 children on maintenance hemodialysis (HD) with polysulfone and cuprophane dialysers.

Results: In HD children absolute numbers of leukocytes, lymphocytes, CD3+, alphabeta, gammadelta T cells and a percentage of gammadelta T cells were decreased versus healthy children. Also, we observed a relative increase of CD3+, CD3+/CD25+ and alphabeta T cells after sessions with cuprophane membranes, and an increase of CD3+/CD25+, alphabeta T cell percentages after sessions with the polysulfone membranes. Additionally we found a decrease of both relative and absolute numbers of gammadelta T cells after HD with polysulfone. In CAPD children we found declined absolute numbers of total lymphocytes, CD3+ and alphabeta T cells and higher relative values of CD3+ and alphabeta T cells versus controls.

Conclusions: The T cell depletion in chronic renal failure (CRF) patients primarily results from uremic-related toxicities, rather than from CAPD or HD-related incompatibilities. We showed a significant decrease of gammadelta T cells in CRF patients on HD, that may be partly responsible for impaired T-dependent responsiveness in that group. The intradialytic changes of gammadelta Tcells may result from a different degree of biocompatibility during the application of various dialysis membranes.

MeSH terms

  • Female
  • Humans
  • Immunity, Cellular
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / immunology
  • Kidney Failure, Chronic / therapy
  • Lymphocyte Count
  • Male
  • Peritoneal Dialysis, Continuous Ambulatory
  • Renal Dialysis
  • T-Lymphocyte Subsets*